Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Dedicated to reinventing the treatment of human disease through the development of innovative47.07M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States47.07M100.00%